Shojaeddin Arista, Fatemi Alireza, Razzaghi Zahra, Pishgahi Mehdi, Jahani Sherafat Somayeh, Razzaghi Mohammadreza, Shahrzad Mohamad Karim, Anaraki Nafiseh, Salehi Chiman, Amiri Aslan
laser Application in Medical Sciences Research Center, Shahid Beheshti University Of Medical Sciences, Tehran, Iran.
Infectious Diseases and Tropical Medicine Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
J Lasers Med Sci. 2023 May 8;14:e14. doi: 10.34172/jlms.2023.14. eCollection 2023.
The coronavirus disease (COVID-19) was extended to the entire population in China and around the world, and its mortality rate was about 3.4%. The impact of laser therapy on chronic respiratory diseases has been shown in previous studies. This study was aimed at examining the effects of laser acupuncture (LA) on patients with severe COVID-19. In the present study, 60 patients with a positive reverse transcription-polymerase chain reaction (RT-PCR) test were assigned to the intervention and control groups (30 patients in each group). The intervention group was treated with LA, that is, laser light with low energy on acupuncture points, once a day for five consecutive days. The participants' mean age in the intervention and control groups was 48.96±12.65 and 53.16±12.28 respectively; 70% of the patients were male and 30% of them were female. IL6 had a significant reduction in the intervention group ( value=0.038) in comparison with the control group ( value=0.535). Furthermore, the mean admission time in the control group was significantly higher than that in the intervention group ( value=0.047). However, the mortality rate in the intervention group was zero, but three patients in the control group died. Our study showed that LA can be used as supportive therapy for routine treatment in patients with severe COVID-19. Moreover, due to LA safety and it's low cost, it could be recommended as an adjuvant to conventional therapy in patients interested in treating their disease with such a method.
冠状病毒病（COVID-19）已在中国乃至全球范围内传播，其死亡率约为3.4%。先前的研究已表明激光疗法对慢性呼吸道疾病的影响。本研究旨在探讨激光针刺（LA）对重症COVID-19患者的疗效。在本研究中，60例逆转录聚合酶链反应（RT-PCR）检测呈阳性的患者被分为干预组和对照组（每组30例）。干预组接受LA治疗，即在穴位上照射低能量激光，每天一次，连续五天。干预组和对照组参与者的平均年龄分别为48.96±12.65岁和53.16±12.28岁；70%的患者为男性，30%为女性。与对照组（值=0.535）相比，干预组的白细胞介素6显著降低（值=0.038）。此外，对照组的平均住院时间显著高于干预组（值=0.047）。然而，干预组的死亡率为零，而对照组有3例患者死亡。我们的研究表明，LA可作为重症COVID-19患者常规治疗的支持性疗法。此外，由于LA安全且成本低廉，对于有兴趣用这种方法治疗疾病的患者，可推荐其作为传统疗法的辅助手段。
